Results 301 to 310 of about 209,459 (341)
Hemostasis and Malignancy [PDF]
Seminars in Thrombosis and Hemostasis, 1998 There is considerable evidence that the hemostatic system is involved in the growth and spread of malignant disease. There is an increased incidence of thromboembolic disease in patients with cancers and hemostatic abnormalities are extremely common in such patients.
John L. Francis +2 more
openaire +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Current Opinion in Hematology, 2013
Blood coagulation exists to halt excessive blood loss. It is paradoxical that surgery and trauma simultaneously represent major risk factors for both hemorrhagic and thrombotic complications. A summary of the available evidence used to guide contemporary approaches to perioperative care will be reviewed.Although the advent of factor-specific products ...
Craig S. Kitchens, Janice W. Lawson
openaire +4 more sources
Blood coagulation exists to halt excessive blood loss. It is paradoxical that surgery and trauma simultaneously represent major risk factors for both hemorrhagic and thrombotic complications. A summary of the available evidence used to guide contemporary approaches to perioperative care will be reviewed.Although the advent of factor-specific products ...
Craig S. Kitchens, Janice W. Lawson
openaire +4 more sources
2023
Inflammation and coagulation are tightly connected, whereby an inflammatory host response will activate coagulation, resulting in a spectrum of coagulopathies that range from a mildly decreased platelet count to disseminated intravascular coagulation (DIC).
Dujardin, Romein W.G. +2 more
openaire +4 more sources
Inflammation and coagulation are tightly connected, whereby an inflammatory host response will activate coagulation, resulting in a spectrum of coagulopathies that range from a mildly decreased platelet count to disseminated intravascular coagulation (DIC).
Dujardin, Romein W.G. +2 more
openaire +4 more sources
American Journal of Hematology, 1990
AbstractHemostatic abnormalities are present in a majority of patients with metastatic cancer. These abnormalities can be categorized as 1) increased platelet aggregation and activation, 2) abnormal activation of coagulation cascade, 3) release of plasminogen activator, and 4) decreased hepatic synthesis of anticoagulant proteins like Protein C and ...
Harry L. Messmore, Sucha Nand
openaire +3 more sources
AbstractHemostatic abnormalities are present in a majority of patients with metastatic cancer. These abnormalities can be categorized as 1) increased platelet aggregation and activation, 2) abnormal activation of coagulation cascade, 3) release of plasminogen activator, and 4) decreased hepatic synthesis of anticoagulant proteins like Protein C and ...
Harry L. Messmore, Sucha Nand
openaire +3 more sources